Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors.
Colby S ShemeshYongsheng WangAndrew AnHao DingPhyllis ChanQi LiuYih-Wen ChenBenjamin WuQiong WuXian WangPublished in: Cancer chemotherapy and pharmacology (2024)
China Clinical Trial Registry Identifier CTR20210219/YP42514. Date of registration 16 March 2021.